Literature DB >> 20848452

Antitumor activity of satraplatin in cisplatin-resistant oral squamous cell carcinoma cells.

Yukio Yamano1, Masashi Shiiba, Kenji Negoro, Ken Nakatani, Atsushi Kasamatsu, Masanobu Yamatoji, Kentaro Sakuma, Kenji Ogoshi, Manabu Iyoda, Keiji Shinozuka, Hidetaka Yokoe, Takeshi Wada, Shigeyuki Fujita, Shunichiro Iwasawa, Yuichi Takiguchi, Hideki Tanzawa, Katsuhiro Uzawa.   

Abstract

BACKGROUND: The aim of the current study was to identify the antitumor activity of satraplatin in paired cisplatin (CDDP)-resistant oral squamous cell carcinoma (OSCC) cell line and its parental cell line.
METHODS: CDDP-resistant (KB-R) cells and parental cells (KB) pair were used. Viability was assessed using the MTT and clonogenic assay. Real-time polymerase chain reaction (PCR), glutathione (GSH) assay, and flow cytometric analysis were used for further assessment.
RESULTS: KB-R cells did not show cross-resistance to satraplatin. The expression status of almost all transporters was upregulated in the KB-R cells. There was no difference in the GSH levels between the KB and KB-R cells. Flow cytometric analysis indicated that with satraplatin the G2/M phase was arrested in the KB-R cells. KB-R cells contain enriched side population cells.
CONCLUSION: These data suggested that satraplatin has antitumor activity against the CDDP-resistant OSCC cells. The mechanism of cross-resistance to platinum agents seems to be multifactorial.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20848452     DOI: 10.1002/hed.21445

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.

Authors:  Fumihiko Uchida; Katsuhiro Uzawa; Atsushi Kasamatsu; Hiroaki Takatori; Yosuke Sakamoto; Katsunori Ogawara; Masashi Shiiba; Hiroki Bukawa; Hideki Tanzawa
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

2.  Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway.

Authors:  Kohei Kawasaki; Atsushi Kasamatsu; Toshiaki Ando; Tomoaki Saito; Takafumi Nobuchi; Ryunosuke Nozaki; Manabu Iyoda; Katsuhiro Uzawa
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.